The Willis Research Network is partnering with risk analytics organisation Metabiota.It is hoped that the partnership with the specialist in infectious diseases modelling will help clients in both the public and private sectors improve their structural resilience to pandemics by better navigating the related human resources, insurance and investment issues.
John Haley, CEO, Willis Towers Watson, said: “The research partnership with Metabiota highlights Willis Towers Watson’s commitment to developing a full understanding of pandemic risk and providing risk transfer tools to enable communities to build greater resilience to pandemic diseases such as COVID-19. We are focused on finding innovative ways to apply our risk, capital and people expertise, and with Metabiota we bring a valuable new partner into that mission.”
Nita Madhav, CEO of Metabiota, added: “Epidemics and pandemics are very complex risks in terms of how they spark, evolve and impact societies and economies. We’re delighted to collaborate with colleagues across Willis Towers Watson to better understand and quantify the risk posed by pandemics. This partnership recognises the scientific leadership, knowledge and expertise that Metabiota brings to assessing epidemic and pandemic risk, to ultimately protect lives and livelihoods.”